Krynica Vitamin SA(PL:KVT)
zł 12.850.00 (0.00%)
PL:KVT
Krynica Vitamin SA financials statements
zł 12.85
At close:0.00 (0.00%)
Krynica Vitamin SA (KVT) Ratios
0 Followers
Krynica Vitamin SA Ratios
PL:KVT's free cash flow for Q2 2026 was zł-5.25M. For the 2026 fiscal year, PL:KVT's free cash flow was decreased by zł-1.97M and operating cash flow was zł-3.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.99 | 0.86 | 0.79 | 0.88 | 0.83 |
| Quick Ratio | 0.56 | 0.50 | 0.44 | 0.48 | 0.53 |
| Cash Ratio | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 |
| Solvency Ratio | 0.31 | 0.20 | 0.05 | 0.19 | 0.19 |
| Operating Cash Flow Ratio | 0.42 | 0.28 | 0.18 | 0.14 | 0.12 |
| Short-Term Operating Cash Flow Coverage | 2.33 | 1.09 | 0.56 | 0.37 | 0.51 |
| Net Current Asset Value | zł -18.66M | zł -36.58M | zł -52.71M | zł -48.88M | zł -58.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.22 | 0.29 | 0.30 | 0.27 |
| Debt-to-Equity Ratio | 0.29 | 0.52 | 0.80 | 0.78 | 0.79 |
| Debt-to-Capital Ratio | 0.22 | 0.34 | 0.44 | 0.44 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.10 | 0.15 | 0.17 | 0.21 |
| Financial Leverage Ratio | 1.83 | 2.39 | 2.78 | 2.56 | 2.92 |
| Debt Service Coverage Ratio | 1.77 | 0.93 | 0.29 | 0.72 | 1.05 |
| Interest Coverage Ratio | 6.03 | 4.20 | -0.67 | 4.19 | 14.88 |
| Debt to Market Cap | 0.18 | 0.39 | 0.32 | 0.36 | 0.22 |
| Interest Debt Per Share | 2.62 | 4.35 | 5.72 | 6.11 | 5.15 |
| Net Debt to EBITDA | 1.03 | 1.55 | 5.05 | 2.21 | 1.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.99% | 16.59% | 14.41% | 17.57% | 14.81% |
| EBIT Margin | 3.99% | 4.49% | -0.61% | 4.81% | 5.66% |
| EBITDA Margin | 8.06% | 8.13% | 3.48% | 8.40% | 8.84% |
| Operating Profit Margin | 3.99% | 4.33% | -0.85% | 4.42% | 5.19% |
| Pretax Profit Margin | 4.16% | 3.56% | -1.87% | 3.75% | 5.31% |
| Net Profit Margin | 3.35% | 3.15% | -1.86% | 3.47% | 3.94% |
| Continuous Operations Profit Margin | 3.35% | 3.15% | -1.86% | 3.47% | 3.94% |
| Net Income Per EBT | 80.59% | 88.56% | 99.20% | 92.46% | 74.19% |
| EBT Per EBIT | 104.41% | 82.14% | 221.55% | 84.78% | 102.31% |
| Return on Assets (ROA) | 6.35% | 5.45% | -2.94% | 5.61% | 6.85% |
| Return on Equity (ROE) | 11.64% | 13.01% | -8.17% | 14.38% | 20.01% |
| Return on Capital Employed (ROCE) | 11.75% | 14.58% | -2.77% | 13.16% | 17.42% |
| Return on Invested Capital (ROIC) | 8.37% | 10.09% | -1.98% | 9.15% | 10.32% |
| Return on Tangible Assets | 6.48% | 5.53% | -2.96% | 5.67% | 6.94% |
| Earnings Yield | 9.29% | 12.29% | -3.97% | 8.21% | 7.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.97 | 7.86 | 7.58 | 7.68 | 7.31 |
| Payables Turnover | 8.79 | 5.73 | 4.33 | 5.30 | 4.66 |
| Inventory Turnover | 10.16 | 8.17 | 7.45 | 7.40 | 10.27 |
| Fixed Asset Turnover | 3.10 | 3.11 | 2.77 | 2.83 | 3.06 |
| Asset Turnover | 1.89 | 1.73 | 1.58 | 1.62 | 1.74 |
| Working Capital Turnover Ratio | -45.09 | -19.44 | -19.13 | -23.61 | -25.92 |
| Cash Conversion Cycle | 31.04 | 27.45 | 12.94 | 28.04 | 7.20 |
| Days of Sales Outstanding | 36.61 | 46.45 | 48.18 | 47.53 | 49.93 |
| Days of Inventory Outstanding | 35.94 | 44.69 | 48.98 | 49.34 | 35.54 |
| Days of Payables Outstanding | 41.51 | 63.69 | 84.22 | 68.84 | 78.28 |
| Operating Cycle | 72.55 | 91.14 | 97.16 | 96.88 | 85.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.32 | 2.53 | 1.76 | 1.17 | 1.11 |
| Free Cash Flow Per Share | 1.85 | 1.65 | 0.90 | -0.14 | -0.60 |
| Dividend Paid and CapEx Coverage Ratio | 3.13 | 2.87 | 1.66 | 0.89 | 0.35 |
| Capital Expenditure Coverage Ratio | 4.92 | 2.87 | 2.05 | 0.89 | 0.65 |
| Operating Cash Flow Coverage Ratio | 0.96 | 0.63 | 0.33 | 0.20 | 0.22 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.08 | 0.06 | 0.04 | 0.03 |
| Free Cash Flow Yield | 17.64% | 20.30% | 6.55% | -1.10% | -3.47% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.71 | 8.12 | -25.22 | 12.18 | 13.68 |
| Price-to-Sales (P/S) Ratio | 0.36 | 0.26 | 0.47 | 0.42 | 0.54 |
| Price-to-Book (P/B) Ratio | 1.25 | 1.06 | 2.06 | 1.75 | 2.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.67 | 4.93 | 15.26 | -90.75 | -28.78 |
| Price-to-Operating Cash Flow Ratio | 4.52 | 3.21 | 7.82 | 11.07 | 15.65 |
| Price-to-Earnings Growth (PEG) Ratio | -5.36 | -0.03 | 0.17 | -0.77 | -0.19 |
| Enterprise Value Multiple | 5.51 | 4.71 | 18.53 | 7.24 | 7.81 |
| Enterprise Value | 158.09M | 148.55M | 231.51M | 229.36M | 272.81M |
| EV to EBITDA | 5.51 | 4.71 | 18.53 | 7.24 | 7.81 |
| EV to Sales | 0.44 | 0.38 | 0.64 | 0.61 | 0.69 |
| EV to Free Cash Flow | 6.97 | 7.36 | 20.97 | -130.69 | -36.83 |
| EV to Operating Cash Flow | 5.55 | 4.79 | 10.75 | 15.94 | 20.03 |
| Tangible Book Value Per Share | 8.06 | 7.41 | 6.51 | 7.23 | 6.13 |
| Shareholders’ Equity Per Share | 8.38 | 7.67 | 6.68 | 7.42 | 6.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.11 | 0.01 | 0.08 | 0.26 |
| Revenue Per Share | 29.08 | 31.66 | 29.32 | 30.78 | 32.26 |
| Net Income Per Share | 0.98 | 1.00 | -0.55 | 1.07 | 1.27 |
| Tax Burden | 0.81 | 0.89 | 0.99 | 0.92 | 0.74 |
| Interest Burden | 1.04 | 0.79 | 3.08 | 0.78 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.11 | 0.13 | 0.06 | 0.04 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.38 | 2.53 | -3.22 | 1.10 | 0.87 |
Currency in PLN
